»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¾Ï ÁöÁö¿ä¹ý ½ÃÀå, 2024-2028³â
¾Ï ÁöÁö¿ä¹ý ½ÃÀåÀº 2023-2028³â¿¡ 62¾ï 5,930¸¸ ´Þ·¯, ¿¹Ãø ±â°£ Áß CAGRÀº 4.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾Ï ÁöÁö¿ä¹ý ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.
ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¾ÏȯÀÚÀÇ À¯º´·ü Áõ°¡, ¾ÏÄ¡·á¿¡ ¼ö¹ÝÇÏ´Â ¸¹Àº ºÎÀÛ¿ë, °³¹ßµµ»ó±¹¿¡¼ÀÇ ¹Ì°³¹ß °¡´É¼º¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁسâ
2024³â
Á¾·á³â
2028³â
¿¹Ãø ±â°£
2024-2028³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â´ëºñ[2024³â]
4%
CAGR
4.3%
ÁõºÐ¾×
62¾ï 5,930¸¸ ´Þ·¯
º» Á¶»ç¿¡¼´Â ¾Ï°ü·Ã Ä¡·á¿¡¼ ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ µîÀåÀ» ÇâÈÄ ¼ö³â°£ ¾Ï ÁöÁö¿ä¹ý ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿äÀÎÀÇ Çϳª·Î ½Äº°Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ Á¦Á¶ Ȱµ¿ÀÇ ¾Æ¿ô¼Ò½Ì ¹× ´Ù¾çÇÑ Àü·«ÀÇ Ã¤ÅÃÀº ½ÃÀåÀÇ Å« ¼ö¿ä·Î ¿¬°áµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå ½ÃÀå ±¸µµ
½ÃÀå ¿¡ÄڽýºÅÛ
½ÃÀåÀÇ Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦3Àå ½ÃÀå ±Ô¸ðÀÇ Æò°¡
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2023³â
½ÃÀå Àü¸Á 2023-2028³â
Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ ¾Ï ÁöÁö¿ä¹ý ½ÃÀå 2018-2022³â
Ä¡·á ¿µ¿ª ºÎ¹® ºÐ¼® 2018-2022³â
À¯Åë ä³Îº° ºÎ¹® ºÐ¼® 2018-2022³â
Áö¿ªº° ºÎ¹® ºÐ¼® 2018-2022³â
±¹°¡º° ºÎ¹® ºÐ¼® 2018-2022³â
Á¦5Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀïÀÇ À§Çù
½ÃÀå ÇöȲ
Á¦6Àå Ä¡·á ¿µ¿ªº° ½ÃÀå ¼¼ºÐÈ
½ÃÀå ¼¼ºÐÈ
ºñ±³ : Ä¡·á ¿µ¿ªº°
ÈÇпä¹ý À¯¹ß¼º ºóÇ÷ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
ÈÇпä¹ý À¯¹ß¼º È£Áß±¸ °¨¼ÒÁõ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
¾Ï ÅëÁõ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
CINV : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
Ä¡·á ¿µ¿ªº° ½ÃÀå ±âȸ
Á¦7Àå À¯Åë ä³Îº° ½ÃÀå ¼¼ºÐÈ
½ÃÀå ¼¼ºÐÈ
ºñ±³ : À¯Åë ä³Îº°
º´¿ø ¾à±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
µå·¯±×½ºÅä¾î¿Í ¾à±¹ ¼Ò¸Å¾÷ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
¿Â¶óÀÎ ÇÁ·Î¹ÙÀÌ´õ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
À¯Åë ä³Îº° ½ÃÀå ±âȸ
Á¦8Àå °í°´ »óȲ
Á¦9Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
ºñ±³ : Áö¿ªº°
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028³â
Áö¿ª »óȲº° ½ÃÀå ±âȸ
Á¦10Àå ÃËÁø¿äÀΡ¤°úÁ¦¡¤±âȸ¡¤¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¡¤¾ïÁ¦¿äÀÎ
Á¦11Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°è ¸®½ºÅ©
Á¦12Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
Amgen Inc.
Baxter International Inc.
Bayer AG
Daiichi Sankyo Co. Ltd.
F. Hoffmann La Roche Ltd.
GlaxoSmithKline Plc
Heron Therapeutics Inc.
Johnson and Johnson Services Inc.
Kyowa Kirin Co. Ltd.
Merck and Co. Inc.
Novartis AG
Purdue Pharma LP
Sanofi SA
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Á¦13Àå ºÎ·Ï
KSA
Cancer Supportive Care Market 2024-2028
The cancer supportive care market is forecasted to grow by USD 6259.3 mn during 2023-2028, accelerating at a CAGR of 4.3% during the forecast period. The report on the cancer supportive care market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases, many side effects associated with cancer treatment, and untapped potential in developing countries.
Market Scope
Base Year 2024
End Year 2028
Series Year 2024-2028
Growth Momentum Accelerate
YOY 2024 4%
CAGR 4.3%
Incremental Value $6259.3 mn
Technavio's cancer supportive care market is segmented as below:
By Therapeutic Area
Chemotherapy-induced anemia
Chemotherapy-induced neutropenia
Cancer pain
CINV
Others
By Distribution Channel
Hospitals pharmacies
Drug stores and retail pharmacies
Online providers
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the advent of biosimilars in cancer-associated treatment as one of the prime reasons driving the cancer supportive care market growth during the next few years. Also, outsourcing of biosimilars manufacturing activities and adoption of various strategies will lead to sizable demand in the market.
The report on the cancer supportive care market covers the following areas:
Cancer Supportive Care Market sizing
Cancer Supportive Care Market forecast
Cancer Supportive Care Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer supportive care market vendors that include Amgen Inc., Baxter International Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Helsinn Healthcare SA, Heron Therapeutics Inc., Johnson and Johnson Services Inc., Kyowa Kirin Co. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, RELIEF THERAPEUTICS Holding SA, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the cancer supportive care market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Therapeutic Area
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Cancer Supportive Care Market 2018 - 2022
Historic Market Size - Data Table on Global Cancer Supportive Care Market 2018 - 2022 ($ million)
4.2 Therapeutic Area segment analysis 2018 - 2022
Historic Market Size - Therapeutic Area Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Therapeutic Area
6.1 Market segments
Chart on Therapeutic Area - Market share 2023-2028 (%)
Data Table on Therapeutic Area - Market share 2023-2028 (%)
6.2 Comparison by Therapeutic Area
Chart on Comparison by Therapeutic Area
Data Table on Comparison by Therapeutic Area
6.3 Chemotherapy-induced anemia - Market size and forecast 2023-2028
Chart on Chemotherapy-induced anemia - Market size and forecast 2023-2028 ($ million)
Data Table on Chemotherapy-induced anemia - Market size and forecast 2023-2028 ($ million)
Chart on Chemotherapy-induced anemia - Year-over-year growth 2023-2028 (%)
Data Table on Chemotherapy-induced anemia - Year-over-year growth 2023-2028 (%)
6.4 Chemotherapy-induced neutropenia - Market size and forecast 2023-2028
Chart on Chemotherapy-induced neutropenia - Market size and forecast 2023-2028 ($ million)
Data Table on Chemotherapy-induced neutropenia - Market size and forecast 2023-2028 ($ million)
Chart on Chemotherapy-induced neutropenia - Year-over-year growth 2023-2028 (%)
Data Table on Chemotherapy-induced neutropenia - Year-over-year growth 2023-2028 (%)
6.5 Cancer pain - Market size and forecast 2023-2028
Chart on Cancer pain - Market size and forecast 2023-2028 ($ million)
Data Table on Cancer pain - Market size and forecast 2023-2028 ($ million)
Chart on Cancer pain - Year-over-year growth 2023-2028 (%)
Data Table on Cancer pain - Year-over-year growth 2023-2028 (%)
6.6 CINV - Market size and forecast 2023-2028
Chart on CINV - Market size and forecast 2023-2028 ($ million)
Data Table on CINV - Market size and forecast 2023-2028 ($ million)
Chart on CINV - Year-over-year growth 2023-2028 (%)
Data Table on CINV - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Therapeutic Area
Market opportunity by Therapeutic Area ($ million)
Data Table on Market opportunity by Therapeutic Area ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Hospitals pharmacies - Market size and forecast 2023-2028
Chart on Hospitals pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Hospitals pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Hospitals pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Hospitals pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Drug stores and retail pharmacies - Market size and forecast 2023-2028
Chart on Drug stores and retail pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Drug stores and retail pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Drug stores and retail pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Drug stores and retail pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online providers - Market size and forecast 2023-2028
Chart on Online providers - Market size and forecast 2023-2028 ($ million)
Data Table on Online providers - Market size and forecast 2023-2028 ($ million)
Chart on Online providers - Year-over-year growth 2023-2028 (%)
Data Table on Online providers - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.4 Baxter International Inc.
Baxter International Inc. - Overview
Baxter International Inc. - Business segments
Baxter International Inc. - Key news
Baxter International Inc. - Key offerings
Baxter International Inc. - Segment focus
12.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.6 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key news
Daiichi Sankyo Co. Ltd. - Key offerings
12.7 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.8 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.9 Heron Therapeutics Inc.
Heron Therapeutics Inc. - Overview
Heron Therapeutics Inc. - Product / Service
Heron Therapeutics Inc. - Key offerings
12.10 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.11 Kyowa Kirin Co. Ltd.
Kyowa Kirin Co. Ltd. - Overview
Kyowa Kirin Co. Ltd. - Product / Service
Kyowa Kirin Co. Ltd. - Key offerings
12.12 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.14 Purdue Pharma LP
Purdue Pharma LP - Overview
Purdue Pharma LP - Product / Service
Purdue Pharma LP - Key offerings
12.15 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.16 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
13.5 Data procurement
13.6 Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations